All lobbying filings
Dendreon Pharmaceuticals, LLC
Dendreon Pharmaceuticals, LLC filed a Q4 report for Dendreon Pharmaceuticals, LLC on February 25, 2026.
Lobbying for Dendreon Pharmaceuticals, LLC
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Feb 25, 2026
Expenses
$59,650
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
1
Lobbying activity
1
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.